ASCITES HEPATIC
Clinical trials for ASCITES HEPATIC explained in plain language.
Never miss a new study
Get alerted when new ASCITES HEPATIC trials appear
Sign up with your email to follow new studies for ASCITES HEPATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection tested to help control advanced liver disease
Disease control Recruiting nowThis is an early-stage study to test the safety and dosing of a new drug called PHIN-214 in people with liver cirrhosis. The drug is given as an injection under the skin, first as a single dose and then as daily doses for up to 28 days. The main goal is to see how much of the dru…
Matched conditions: ASCITES HEPATIC
Phase: PHASE1 • Sponsor: PharmaIN • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New liver procedure aims to sidestep debilitating brain fog
Disease control Recruiting nowThis study is testing a new way of placing a stent during a common liver procedure called TIPS. The goal is to see if starting with a smaller stent opening can reduce the risk of post-surgery brain complications (hepatic encephalopathy), which often cause confusion and memory pro…
Matched conditions: ASCITES HEPATIC
Phase: NA • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New stent offers hope for controlling Life-Threatening liver complications
Disease control Recruiting nowThis study is testing a new medical device called the LIVERTY TIPS Stent Graft. It aims to control severe complications of advanced liver scarring (cirrhosis), such as dangerous internal bleeding and fluid buildup in the abdomen. Researchers will follow 166 patients for a year to…
Matched conditions: ASCITES HEPATIC
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC